Ron Swanstrom, PhD, the Charles P. Postelle, Jr. Distinguished Professor of Biochemistry & Biophysics, was featured on Science Friday on NPR, discussing COVID-19 treatments along with fellow virologist Adam Lauring, PhD, at the University of Michigan.
Ron Swanstrom, PhD, director of the UNC Center for AIDS Research and member of the UNC Lineberger Comprehensive Cancer Center, was a featured guest on NPR’s Science Friday, discussing FDA-authorized COVID-19 treatments: Merck’s pill molnupiravir and Pfizer’s pill paxlovid.
From Science Friday: “The two pills join remdesivir, an infusion-only drug, as antiviral compounds that attack the SARS-CoV2 virus in different ways. But how exactly do they work, how well do they work, and what makes them complicated to use in real life?”
Dr. Swanstrom is the Charles P. Postelle, Jr. Distinguished Professor of Biochemistry & Biophysics and holds a joint appointment in the UNC Department of Microbiology & Immunology. He was the 2020 recipient of the Hyman L. Battle Distinguished Cancer Research Award.